Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.15363 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.13039 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.1355 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.08565 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.07945 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.17757 | 6 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.15221 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.11437 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.11144 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.12016 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.1155 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.1141 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12399 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.1208 | 6 |